3-O-substituted benzyl pyridazinone derivatives as COX inhibitors. 2002

Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
Discovery Chemistry, Dr. Reddy's Research Foundation, Bollaram Road, Miyapur, Hyderabad 500050, India.

New 3-O-substituted benzyl pyridazinone compounds have been synthesised and evaluated for their cyclooxygenase inhibitory activity and COX-2 selectivity. Among the compounds synthesised, three compounds (11b-11d) have shown in vitro COX-2 selectivity. These compounds have been evaluated for their in vivo potential using carrageenan-induced rat paw edema assay. One compound (11b) showed 32% anti-inflammatory activity at 30 mgkg(-1) dose.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D011451 Prostaglandin-Endoperoxide Synthases Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor. Fatty Acid Cyclo-Oxygenase,PGH Synthase,Prostaglandin H Synthase,Prostaglandin Synthase,Prostaglandin-Endoperoxide Synthase,Arachidonic Acid Cyclooxygenase,Cyclo-Oxygenase,Cyclooxygenase,Cyclooxygenases,Hydroperoxide Cyclase,PGH2 Synthetase,Prostaglandin Cyclo-Oxygenase,Prostaglandin Cyclooxygenase,Prostaglandin Endoperoxide Synthetase,Prostaglandin G-H Synthase,Prostaglandin H2 Synthetase,Prostaglandin Synthetase,Cyclase, Hydroperoxide,Cyclo Oxygenase,Cyclo-Oxygenase, Fatty Acid,Cyclo-Oxygenase, Prostaglandin,Cyclooxygenase, Arachidonic Acid,Cyclooxygenase, Prostaglandin,Endoperoxide Synthetase, Prostaglandin,Fatty Acid Cyclo Oxygenase,G-H Synthase, Prostaglandin,Prostaglandin Cyclo Oxygenase,Prostaglandin Endoperoxide Synthases,Prostaglandin G H Synthase,Synthase, PGH,Synthase, Prostaglandin,Synthase, Prostaglandin G-H,Synthase, Prostaglandin H,Synthase, Prostaglandin-Endoperoxide,Synthases, Prostaglandin-Endoperoxide,Synthetase, PGH2,Synthetase, Prostaglandin,Synthetase, Prostaglandin Endoperoxide,Synthetase, Prostaglandin H2
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D016861 Cyclooxygenase Inhibitors Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. Cyclo-Oxygenase Inhibitor,Cyclooxygenase Inhibitor,Prostaglandin Endoperoxide Synthase Inhibitor,Prostaglandin Endoperoxide Synthase Inhibitors,Prostaglandin Synthase Inhibitor,Prostaglandin Synthase Inhibitors,Prostaglandin Synthesis Antagonist,Prostaglandin Synthesis Antagonists,Cyclo-Oxygenase Inhibitors,Inhibitors, Cyclo-Oxygenase,Inhibitors, Cyclooxygenase,Inhibitors, Prostaglandin Synthase,Inhibitors, Prostaglandin-Endoperoxide Synthase,Antagonist, Prostaglandin Synthesis,Antagonists, Prostaglandin Synthesis,Cyclo Oxygenase Inhibitor,Cyclo Oxygenase Inhibitors,Inhibitor, Cyclo-Oxygenase,Inhibitor, Cyclooxygenase,Inhibitor, Prostaglandin Synthase,Inhibitors, Cyclo Oxygenase,Inhibitors, Prostaglandin Endoperoxide Synthase,Synthase Inhibitor, Prostaglandin,Synthesis Antagonist, Prostaglandin

Related Publications

Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
November 2019, Bioorganic chemistry,
Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
February 2016, Bioorganic & medicinal chemistry letters,
Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
April 2016, Archives of pharmacal research,
Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
March 2001, Farmaco (Societa chimica italiana : 1989),
Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
August 2022, Molecules (Basel, Switzerland),
Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
June 2019, European journal of medicinal chemistry,
Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
October 2003, Bioorganic & medicinal chemistry letters,
Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
March 2017, European journal of medicinal chemistry,
Vamsee Krishna Chintakunta, and Venkateswarlu Akella, and Manohar Sharma Vedula, and Prem Kumar Mamnoor, and Parimal Mishra, and Seshagiri Rao Casturi, and Akhila Vangoori, and Ramanujam Rajagopalan
January 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!